Status:
UNKNOWN
The Comparison Between the Therapeutic Affect of Intravitreal Diclophenac and Triamcinolone in Persistent Uveitic Cystoids Macular Edema
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Uveitis
Cystoid Macular Edema
Eligibility:
All Genders
Phase:
PHASE1
Brief Summary
Cystoids macular edema (CME) is one of the most common causes of low vision due to uveitis. The treatment for reducing the intra-ocular inflammation can decrease the macular edema. In some patients, C...
Eligibility Criteria
Inclusion
- cystoids macular edema which is diagnosed by OCT and flurocein angiography
- 5/200 \< Visual acuity \< 20/50
- resistance to routine treatment (oral treatment, periocular injection)
Exclusion
- history of retinal disease cause macular edema like diabetes
- arterial occlusion
- monocular patients
- patients candidate for intra-ocular operation
- history of glaucoma or ocular hypertension
- any cataract that would interfere with OCT
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00893854
Last Update
May 6 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmic Research Center
Tehran, Tehran Province, Iran, 166666